The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review)
Open accessAbstract
Hypoxia‑ischemia (H‑I) is frequently observed in perinatal asphyxia and other diseases. It can lead to serious cardiac injury, cerebral damage, neurological disability and mortality. Previous studies have demonstrated that the phosphatidylinositol‑3 kinase (PI3K)/protein kinase B (Akt) signaling pathway, which regulates a wide range of cellular functions, is involved in the resistance response to H‑I through the activation of proteins associated with survival and inactivation of apoptosis‑associated proteins. It can also regulate the expression of hypoxia‑induced factor‑1α (HIF‑1α). HIF‑1α can further regulate the expression of downstream proteins involved in glucose metabolism and angiogenesis, such as vascular endothelial growth factor and erythropoietin, to facilitate ischemic adaptation. Notably, HIF‑1α may also induce detrimental effects. The effects of HIF‑1 on ischemic outcomes may be dependent on the H‑I duration, animal age and species. Thus, further investigation of the PI3K/Akt signaling pathway may provide further insights of the potential targets for treating diseases accompanied by H‑I.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601 · cited 1×
“BNIP3 reduces increased levels of ROS via HIF-1-inducible mitochondrial autophagy (79), meanwhile causing mitochondrial dysfunction, opening of the mitochondrial permeability transition pores, membrane depolarization and cell death.”
RetractedThe phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981 · cited 1×
“One of the potent stimuli for increased VEGF production is hypoxia (71).”
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Ischemia and reperfusion—from mechanism to translation
Eltzschig, H. K., & Eckle, T. (2011) · Nature Medicine · doi:10.1038/nm.2507 · Cited by 3,382
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
(2000) · PubMed · Cited by 1,445
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
Fruman, D. A., Meyers, R. E., & Cantley, L. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.481 · Cited by 1,355
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G. N., & Semenza, G. L. (2005) · Blood · doi:10.1182/blood-2004-07-2958 · Cited by 1,154
Ferriero, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041996 · Cited by 1,142
PI3K/AKT signaling pathway and cancer: An updated review
Martini, M., De Santis, M. C., Braccini, L., Gulluni, F., & Hirsch, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.912836 · Cited by 1,020
Links between metabolism and cancer
Dang, C. V. (2012) · Genes & Development · doi:10.1101/gad.189365.112 · Cited by 998
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
Protein–protein interactions define specificity in signal transduction
Pawson, T., & Nash, P. (2000) · Genes & Development · doi:10.1101/gad.14.9.1027 · Cited by 780
Regulation of glut1 mRNA by Hypoxia-inducible Factor-1
Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F., & Maity, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010144200 · Cited by 771
Childhood Outcomes after Hypothermia for Neonatal Encephalopathy
Shankaran, S., Pappas, A., McDonald, S. A., Vohr, B. R., Hintz, S. R., Yolton, K., Gustafson, K. E., Leach, T. M., Green, C., Bara, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112066 · Cited by 741
Hu, X., Yu, S. P., Fraser, J. L., Lu, Z., Ogle, M. E., Wang, J.-A., & Wei, L. (2008) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.07.071 · Cited by 621
Hypoxia and mitochondrial oxidative metabolism
Solaini, G., Baracca, A., Lenaz, G., & Sgarbi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.011 · Cited by 608
HIF1 and oxygen sensing in the brain
Sharp, F. R., & Bernaudin, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1408 · Cited by 568
Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
Courtnay, R., Ngo, D. C., Malik, N., Ververis, K., Tortorella, S. M., & Karagiannis, T. C. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3858-x · Cited by 567
From angiogenesis to neuropathology
Greenberg, D. A., & Jin, K. (2005) · Nature · doi:10.1038/nature04481 · Cited by 532
Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
Graupera, M., Guillermet-Guibert, J., Foukas, L. C., Phng, L.-K., Cain, R. J., Salpekar, A., Pearce, W., Meek, S., Millan, J., Cutillas, P. R., et al. (2008) · Nature · doi:10.1038/nature06892 · Cited by 520
Semenza, G. L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.006 · Cited by 483
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Semenza, G. L. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.009 · Cited by 469
Regulation of angiogenesis by hypoxia-inducible factor 1
Hirota, K., & Semenza, G. L. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.12.003 · Cited by 464
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
Wong, C. C.-L., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., Fraley, S. I., Wong, C.-M., Khoo, U.-S., Ng, I. O.-L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113483108 · Cited by 437
Activation of the HIF pathway in cancer
Maxwell, P. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00193-3 · Cited by 426
Angiogenesis Ischemic and Neoplastic Disorders
Semenza, G. L. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152418 · Cited by 386
Glucose transporters in cancer metabolism
Adekola, K., Rosen, S. T., & Shanmugam, M. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328356da72 · Cited by 382
Gray, M. J., Zhang, J., Ellis, L. M., Semenza, G. L., Evans, D. B., Watowich, S. S., & Gallick, G. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208513 · Cited by 372
Baranova, O., Miranda, L. F., Pichiule, P., Dragatsis, I., Johnson, R. S., & Chavez, J. C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0449-07.2007 · Cited by 350
Patten, R. D., Pourati, I., Aronovitz, M. J., Baur, J., Celestin, F., Chen, X., Michael, A., Haq, S., Nuedling, S., Grohe, C., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000144126.57786.89 · Cited by 336
Kido, M., Du, L., Sullivan, C. C., Li, X., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.045 · Cited by 331
Zaman, K., Ryu, H., Hall, D., O'Donovan, K., Lin, K.-I., Miller, M. P., Marquis, J. C., Baraban, J. M., Semenza, G. L., & Ratan, R. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09821.1999 · Cited by 320
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
Semenza, G. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9081-2 · Cited by 281
PHDs overactivation during chronic hypoxia “desensitizes” HIFα and protects cells from necrosis
Ginouvès, A., Ilc, K., Macías, N., Pouysségur, J., & Berra, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705680105 · Cited by 256
Hypoxia-inducible factor 1 and breast cancer metastasis
Liu, Z.-J., Semenza, G. L., & Zhang, H.-F. (2015) · Journal of Zhejiang University-SCIENCE B · doi:10.1631/jzus.b1400221 · Cited by 252
Helton, R., Cui, J., Scheel, J. R., Ellison, J. A., Ames, C., Gibson, C., Blouw, B., Ouyang, L., Dragatsis, I., Zeitlin, S., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4555-04.2005 · Cited by 240
Wong, C. C.-L., Zhang, H., Gilkes, D. M., Chen, J., Wei, H., Chaturvedi, P., Hubbi, M. E., & Semenza, G. L. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0855-y · Cited by 225
Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., & Harris, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9501 · Cited by 221
Higgins, R. D., Raju, T., Edwards, A. D., Azzopardi, D. V., Bose, C. L., Clark, R. H., Ferriero, D. M., Guillet, R., Gunn, A. J., Hagberg, H., et al. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.08.004 · Cited by 217
Hypoxia inducible factor as a therapeutic target for atherosclerosis
Jain, T., Nikolopoulou, E. A., Xu, Q., & Qu, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.09.003 · Cited by 215
The von Hippel–Lindau tumor suppressor protein
Ivan, M., & Kaelin, W. G. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00152-0 · Cited by 211
Cellular responses to EGFR inhibitors and their relevance to cancer therapy
Dutta, P. R., & Maity, A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.02.006 · Cited by 181
Xiao, Y., Peng, H., Hong, C., Chen, Z., Deng, X., Wang, A., Yang, F., Yang, L., Chen, C., & Qin, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479401 · Cited by 164 · cited 2×
“Previous studies have shown that HIF-1 α is subjected to regulation by the PI3K/Akt/mTOR (20,25) and PI3K/Akt/FRAP (26) signaling pathways.”
Translational control of gene expression during hypoxia
van den Beucken, T., Koritzinsky, M., & Wouters, B. G. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.7.2972 · Cited by 163
Hypoxia Inducible Factor 1 as a Therapeutic Target in Ischemic Stroke
Shi, H. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789760779 · Cited by 161
Hypoxia-Inducible Factor-1α Mediates Hypoxia-Induced Delayed Neuronal Death That Involves p53
Halterman, M. W., Miller, C. C., & Federoff, H. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-06818.1999 · Cited by 159
Yang, X.-M., Wang, Y.-S., Zhang, J., Li, Y., Xu, J.-F., Zhu, J., Zhao, W., Chu, D.-K., & Wiedemann, P. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2591 · Cited by 158
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Simon, M. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.007 · Cited by 136
HIF-1α and p53 Promote Hypoxia-Induced Delayed Neuronal Death in Models of CNS Ischemia
Halterman, M. W., & Federoff, H. J. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7160 · Cited by 127
Hu, X., Wei, L., Taylor, T. M., Wei, J., Zhou, X., Wang, J., & Yu, S. P. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00013.2010 · Cited by 124
Wang, Z., Zhang, H., Xu, X., Shi, H., Yu, X., Wang, X., Yan, Y., Fu, X., Hu, H., Li, X., et al. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.05.006 · Cited by 112
Self-citationHypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium
Chen, J., & Meyrick, B. O. (2003) · Laboratory Investigation · doi:10.1038/labinvest.3700027 · Cited by 108
A role for hypoxia-inducible factor-1α in desferoxamine neuroprotection
Hamrick, S. E. G., McQuillen, P. S., Jiang, X., Mu, D., Madan, A., & Ferriero, D. M. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.080 · Cited by 107
Khan, M., Varadharaj, S., Ganesan, L. P., Shobha, J. C., Naidu, M. U. R., Parinandi, N. L., Tridandapani, S., Kutala, V. K., & Kuppusamy, P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01072.2005 · Cited by 105
Li, D., Qu, Y., Mao, M., Zhang, X., Li, J., Ferriero, D. M., & Mu, D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.102 · Cited by 101
He, Z., Opland, D. M., Way, K. J., Ueki, K., Bodyak, N., Kang, P. M., Izumo, S., Kulkarni, R. N., Wang, B., Liao, R., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000209500.15801.4e · Cited by 94
Wang, Z., Wang, Y., Ye, J., Lu, X., Cheng, Y. H., Xiang, L., Chen, L., Feng, W., Shi, H., Yu, X., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12346 · Cited by 94
Self-citationMinet, E., Michel, G., Remacle, J., & Michiels, C. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.5.3.253 · Cited by 92
PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting
Ciuffreda, L., Falcone, I., Incani, U. C., Curatolo, A. D., Conciatori, F., Matteoni, S., Vari, S., Vaccaro, V., Cognetti, F., & Milella, M. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.07.002 · Cited by 88
Chen, C., Hu, Q., Yan, J., Lei, J., Qin, L., Shi, X., Luan, L., Yang, L., Wang, K., Han, J., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.004652.x · Cited by 86
Li, L., Qu, Y., Mao, M., Xiong, Y., & Mu, D. (2008) · Brain Research · doi:10.1016/j.brainres.2007.12.059 · Cited by 86
Tian, T., Nan, K., Wang, S., Liang, X., Lu, C.-X., Guo, H., Wang, W., & Ruan, Z. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq085 · Cited by 84
Zhang, F., Ding, T., Yu, L., Zhong, Y., Dai, H., & Yan, M. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01382.x · Cited by 79
Guo, S., Miyake, M., Liu, K. J., & Shi, H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05877.x · Cited by 79
Kunze, R., Zhou, W., Veltkamp, R. C., Wielockx, B., Breier, G., & Marti, H. H. (2012) · Stroke · doi:10.1161/strokeaha.112.669598 · Cited by 77
Filippi, I., Morena, E., Aldinucci, C., Carraro, F., Sozzani, S., & Naldini, A. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24666 · Cited by 66
Sun, Y., Chen, X., Zhang, X., Shen, X., Wang, M., Wang, X., Liu, W.-C., Liu, C., Liu, J., Liu, W., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00257 · Cited by 57
Karar, J., Cerniglia, G. J., Lindsten, T., Koumenis, C., & Maity, A. M. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21144 · Cited by 49
Bai, W., Xing, Y., Wang, B., Lu, X., Wang, Y., Sun, Y., Liu, X., Guo, T., & Zhao, Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/813247 · Cited by 48
Sumida, A., Horiba, M., Ishiguro, H., Takenaka, H., Ueda, N., Ooboshi, H., Opthof, T., Kadomatsu, K., & Kodama, I. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp386 · Cited by 48
Dimova, E. Y., Michiels, C., & Kietzmann, T. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649358 · Cited by 43
HIF-1 is the Commander of Gateways to Cancer
Ma, N. (2011) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000054 · Cited by 41
Sun, Y., Chen, X., Zhang, X., Shen, X., Wang, M., Wang, X., Liu, W.-C., Liu, C., Liu, J., Liu, W., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00392 · Cited by 41
Neuroprotective effect of pAkt and HIF-1 α on ischemia rats
Bao-nan, L., Han, B., & Liu, F. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60025-0 · Cited by 38
Liu, M., Li, G., Peng, L., Qu, S., Zhang, Y., Peng, J., Luo, X.-Y., Hu, H.-J., Ren, Z., Liu, Y., et al. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2658-5 · Cited by 36
Poitz, D. M., Augstein, A., Hesse, K., Christoph, M., Ibrahim, K. S., Braun-Dullaeus, R. C., Strasser, R. H., & Schmeißer, A. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.10.001 · Cited by 35
New Insights into the Mechanisms of Mitochondrial Preconditioning-Triggered Neuroprotection
Correia, S. C., Cardoso, S., Santos, R. X., Carvalho, C., Santos, M. S., Perry, G. L., Smith, M. A., & Moreira, P. I. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072490 · Cited by 32
Huang, J., Zhang, L., Qu, Y., Zhou, Y., Zhu, J., Li, Y., Zhu, T., Zhao, F., Tang, J., & Mu, D. (2017) · Brain Research · doi:10.1016/j.brainres.2017.11.005 · Cited by 26
Wang, Z., & Si, L. (2013) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2013.766914 · Cited by 25
Self-citationMovsas, T. Z., Weiner, R. L., Greenberg, M. B., Holtzman, D. M., & Galindo, R. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00232 · Cited by 21
Yao, H.-C., ZHOU, M., Zhou, Y., WANG, L.-H., ZHANG, D.-Y., Han, Q.-F., LIU, T., WU, L., Tian, K., & Zhang, M. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4648 · Cited by 19
Kt, J., Shi, Y., Zhang, Y., Ma, H., Js, L., & Fl, X. (2015) · PubMed · Cited by 13
Cited by
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667
Targeting immunometabolism as an anti-inflammatory strategy
Pålsson-McDermott, E. M., & O’Neill, L. A. J. (2020) · Cell Research · doi:10.1038/s41422-020-0291-z · Cited by 577
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C.-H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 383
Metadata
- Authors
- Zhang, Z., Yao, L., Yang, J., Wang, Z., & Du, G.
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2018-08-09
- Volume
- 18
- Issue
- 4
- Pages
- 3547-3554
- ISSN
- 1791-2997 (ISSN-L)
- 1791-3004
- OpenAlex
- W2885551446
- Cited by
- 404
- References
- 90
- FWCI
- 27.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.